Showing results (1-10 of 514) with videos related to
Sort By:
Pageof 52
Clinical Orthopaedics and Related Research|March 1, 1995
Facilitation and suppression of bone metastasisG R Mundy, T YonedaCalcified Tissue International|March 1, 1982
Release of the lymphokine osteoclast activating factor requires cyclic AMP accumulationT Yoneda, G R MundyThe Journal of Experimental Medicine|January 1, 1979
Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytesT Yoneda, G R MundyThe Journal of Experimental Medicine|August 1, 1979
Monocytes regulate osteoclast-activating factor production by releasing prostaglandinsT Yoneda, G R MundySeminars in Oncology|May 11, 2001
Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironmentG R Mundy, T Yoneda, T HiragaBreast Cancer Research and Treatment|January 1, 1994
Osteolytic bone metastasis in breast cancerT Yoneda, A Sasaki, G R MundyCancer Research|June 5, 2001
The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastasesT Hiraga, P J Williams, G R Mundy, et al.Molecular Endocrinology (Baltimore, Md.)|October 1, 1993
Hormonal regulation of pp60c-src expression during osteoclast formation in vitroT Yoneda, M Niewolna, C Lowe, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitroT A Guise, T Yoneda, A J Yates, et al.Endocrinology|August 1, 1991
Differentiation of HL-60 cells into cells with the osteoclast phenotypeT Yoneda, M M Alsina, J L Garcia, et al.Pageof 52